RACK1 and acute lymphoblastic leukemia: More recently, it was shown that PKCα activity promotes BCL-2 phosphorylation and chemoresistance in ALL [19], and by inducing RACK1 over-expression PKCα is responsible of T-ALL resistance to vincristine and prednisone [20].